Buy Strattera (Atomoxetine)

Atomoxetine potently and highly selectively inhibits presynaptic membrane transport proteins that reuptake norepinephrine, serotonin, and dopamine. In tissue microdialysis studies, atomoxetine has been shown to triple the levels of norepinephrine and dopamine in the prefrontal cortex, but does not alter dopamine levels in the striatum and nucleus accumbens. At therapeutic doses, atomoxetine also acts as an NMDA receptor antagonist.[8] The role of such antagonism in the therapeutic profile of atomoxetine remains to be clarified, however, recent literature suggests that dysfunction of the glutamatergic system may play a role in the etiology and pathogenesis of ADHD. Atomoxetine does not have clinically significant affinity for serotonin, acetylcholine and adrenoreceptors.

Attention deficit hyperactivity disorder.

• Dizziness,
• drowsiness,
• early morning awakening,
• insomnia,
• irritability,
• emotional lability;
• mydriasis;
• palpitations,
• sinus tachycardia;
• abdominal pain,
• vomiting,
• dyspepsia,
• loss of appetite,
• anorexia,
• weight loss;
• increased sweating,
• dermatitis,
• itching,
• rash,
• angioedema,
• urticaria;
• decreased libido,
• difficulty urinating,
• urinary retention,
• dysmenorrhea,
• impaired ejaculation and erection,
• impaired orgasm,
• prostatitis;
• fatigue,
• flu.

Overdose

Symptoms: drowsiness, agitation, hyperactivity, behavioral disorders, gastrointestinal dysfunction, mydriasis, tachycardia, dry mouth, convulsions.

Treatment: gastric lavage, activated charcoal, monitoring of cardiac activity and vital signs, artificial ventilation of the lungs, symptomatic and supportive therapy.

Contraindications

• Hypersensitivity,
• angle-closure glaucoma,
• simultaneous use of MAO inhibitors,
• lactation period,
• children's age (up to 6 years).

With caution

• arterial hypertension,
• tachycardia,
• cerebrovascular accident,
• arterial hypotension and diseases that cause it,
• pregnancy.

Inside, regardless of the meal (or during meals), 1 time per day in the morning or, if side effects occur, 2 times a day (morning and late afternoon or early evening).

Children and adolescents weighing up to 70 kg: the recommended initial daily dose is 0.5 mg / kg, which is increased to 1-2 mg / kg no earlier than 3 days later. If there is no improvement in the condition, the daily dose can be increased to a maximum of -1.8 mg / kg (or 120 mg) no earlier than 2-4 weeks after the start of the drug. The recommended maintenance dose is 1.2 mg/kg/day.

Children and adolescents weighing more than 70 kg and adults: the recommended initial daily dose is 40 mg, which is increased to 80 mg no earlier than 3 days later. In the absence of improvement in the condition, the daily dose can be increased to a maximum of -120 mg no earlier than 2-4 weeks after the start of the drug. The recommended maintenance dose is 80 mg.

The drug should not be used for at least 2 weeks after discontinuation of MAO inhibitors. Treatment with MAO inhibitors should not begin within 2 weeks after discontinuation of the drug. Beta2-agonists - the risk of side effects from the cardiovascular system (increased heart rate and blood pressure). Vasoconstrictor drugs - risk of high blood pressure. Drugs that affect the secretion of norepinephrine - possibly increased or synergistic action.

You can buy Strattera from our website absolutely legally.

Delivery is carried out to all countries in the world, which do not have an official ban on receiving and sending mail (mainly island countries).

We guarantee that you will receive your parcel with Strattera without any problems at customs (we have our own delivery channels to countries with strict customs).

We guarantee a refund if your package has not been delivered to you for any reason, according to PayPal protection policy.

Due to Quarantine, delivery time may increase slightly, but still delivery remains within reasonable limits and does not exceed the delivery time during Christmas sales.

There is no prescription required!

You can legally buy Strattera our website without prescription! 

Treatment should be under the supervision of a physician experienced in working with patients with Attention Deficit Hyperactivity Disorder. Care should be taken when prescribing the drug for conditions and diseases leading to hypotension. In the event of jaundice or changes in laboratory parameters indicating a violation of liver function, treatment should be discontinued. During the period of treatment, care should be taken when engaging in potentially hazardous activities.